Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
5.04
-0.17 (-3.26%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Neuphoria Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Cash & Equivalents | 4.34 | 12.61 | 12.1 | 23.13 | 21.37 | 3.16 | Upgrade
|
| Cash & Short-Term Investments | 4.34 | 12.61 | 12.1 | 23.13 | 21.37 | 3.16 | Upgrade
|
| Cash Growth | -57.13% | 4.17% | -47.66% | 8.23% | 576.06% | -67.77% | Upgrade
|
| Accounts Receivable | - | - | - | - | 0.14 | 0.01 | Upgrade
|
| Other Receivables | 0.04 | 0.13 | 0.43 | 4.67 | 0.7 | 2.05 | Upgrade
|
| Receivables | 0.04 | 0.13 | 0.43 | 4.67 | 0.85 | 2.06 | Upgrade
|
| Prepaid Expenses | 0.02 | 0.46 | 0.8 | 1.01 | 0.65 | 0.53 | Upgrade
|
| Restricted Cash | - | - | - | - | 0.33 | - | Upgrade
|
| Total Current Assets | 4.4 | 13.19 | 13.33 | 28.81 | 23.19 | 5.75 | Upgrade
|
| Property, Plant & Equipment | 0.15 | 0.22 | 0.33 | 0.46 | 0.65 | 0.73 | Upgrade
|
| Goodwill | 8.41 | 8.69 | 8.69 | 8.87 | 9.3 | 8.89 | Upgrade
|
| Other Intangible Assets | 5.14 | 5.47 | 6.13 | 6.78 | 7.46 | 8.12 | Upgrade
|
| Other Long-Term Assets | 0.07 | 0.08 | 0.08 | 0.08 | 0.09 | 0.3 | Upgrade
|
| Total Assets | 18.17 | 27.65 | 28.56 | 45 | 40.68 | 23.79 | Upgrade
|
| Accounts Payable | 1.53 | 2.24 | 1.44 | 1.07 | 0.77 | 0.87 | Upgrade
|
| Accrued Expenses | 0.48 | 1.46 | 1.19 | 1.13 | 0.87 | 0.73 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | - | 3.58 | Upgrade
|
| Current Portion of Leases | 0.12 | 0.12 | 0.11 | 0.11 | 0.13 | 0.53 | Upgrade
|
| Total Current Liabilities | 2.13 | 3.83 | 2.74 | 2.31 | 1.77 | 5.71 | Upgrade
|
| Long-Term Debt | - | - | - | - | - | 4.32 | Upgrade
|
| Long-Term Leases | 0.05 | 0.12 | 0.24 | 0.37 | 0.52 | 0.02 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.84 | 0.96 | 1.1 | 1.24 | 1.38 | 1.52 | Upgrade
|
| Other Long-Term Liabilities | 1.39 | 5.25 | 2.47 | 1.86 | 1.32 | 3.43 | Upgrade
|
| Total Liabilities | 4.42 | 10.16 | 6.55 | 5.79 | 5 | 15.04 | Upgrade
|
| Common Stock | 0 | - | - | 149.99 | 142.59 | 102.29 | Upgrade
|
| Additional Paid-In Capital | 198.19 | 198.48 | 187.55 | - | - | - | Upgrade
|
| Retained Earnings | -180.73 | -177.98 | -162.48 | -119.41 | -115.49 | -102.79 | Upgrade
|
| Comprehensive Income & Other | -3.72 | -3.01 | -3.06 | 8.63 | 8.58 | 9.26 | Upgrade
|
| Shareholders' Equity | 13.75 | 17.49 | 22.01 | 39.21 | 35.69 | 8.76 | Upgrade
|
| Total Liabilities & Equity | 18.17 | 27.65 | 28.56 | 45 | 40.68 | 23.79 | Upgrade
|
| Total Debt | 0.17 | 0.24 | 0.35 | 0.48 | 0.65 | 8.45 | Upgrade
|
| Net Cash (Debt) | 4.18 | 12.37 | 11.75 | 22.65 | 20.72 | -5.29 | Upgrade
|
| Net Cash Growth | -53.92% | 5.27% | -48.12% | 9.32% | - | - | Upgrade
|
| Net Cash Per Share | 0.00 | 0.01 | 0.01 | 0.02 | 0.03 | -0.01 | Upgrade
|
| Filing Date Shares Outstanding | 1.76 | 3,118 | 1,469 | 1,353 | 1,008 | 626.19 | Upgrade
|
| Total Common Shares Outstanding | 1.63 | 2,385 | 1,469 | 1,353 | 1,008 | 626.19 | Upgrade
|
| Working Capital | 2.26 | 9.36 | 10.59 | 26.49 | 21.42 | 0.04 | Upgrade
|
| Book Value Per Share | 8.44 | 0.01 | 0.01 | 0.03 | 0.04 | 0.01 | Upgrade
|
| Tangible Book Value | 0.2 | 3.33 | 7.19 | 23.57 | 18.93 | -8.26 | Upgrade
|
| Tangible Book Value Per Share | 0.13 | 0.00 | 0.00 | 0.02 | 0.02 | -0.01 | Upgrade
|
| Machinery | - | - | - | - | 0.08 | 0.95 | Upgrade
|
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.